Literature DB >> 3997247

Characterization of antibodies mediating protection and cure of Trypanosoma musculi infection in mice.

D S Wechsler, P A Kongshavn.   

Abstract

Plasma samples were collected from mice infected with Trypanosoma musculi at different times postinfection and administered to naive recipient mice either before or during T. musculi infection. The protective and curative activities of these plasma samples were shown to increase as the time of collection postinfection increased; plasma collected at 14 days postinfection was partially protective and partially curative, whereas that collected at 28 days postinfection was completely protective and curative. The curative activity was labile to heat treatment (30 min at 56 degrees C), whereas the protective activity was heat stable. Additional kinetic parameters relating to the efficacy of protection were investigated. Evidence is presented that both activities are immunoglobulin in nature. Protein A-Sepharose chromatography indicated that the activities are associated with the immunoglobulin G2a or immunoglobulin G3 subclasses of immunoglobulin G. The curative antibody appears to be intrinsically heat labile, since heat treatment of a purified immunoglobulin preparation abolished the ability to cure. Studies on the mechanism of parasite elimination from blood suggest that the process not only requires antibody but is also complement dependent.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3997247      PMCID: PMC261264          DOI: 10.1128/iai.48.3.787-794.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose.

Authors:  P L Ey; S J Prowse; C R Jenkin
Journal:  Immunochemistry       Date:  1978-07

2.  Immunological clearance of 75Se-labelled Trypanosoma brucei in mice. I. Aspects of the radiolabelling technique.

Authors:  P H Holmes; J A MacAskill; D D Whitelaw; F W Jennings; G M Urquhart
Journal:  Immunology       Date:  1979-03       Impact factor: 7.397

Review 3.  The role of cell-mediated immunity in bacterial infections.

Authors:  H Hahn; S H Kaufmann
Journal:  Rev Infect Dis       Date:  1981 Nov-Dec

4.  Immunological clearance of 75Se-labelled Trypanosoma brucei in mice. III. Studies in animals with acute infections.

Authors:  J A Macaskill; P H Holmes; F W Jennings; G M Urquhart
Journal:  Immunology       Date:  1981-08       Impact factor: 7.397

5.  The effect of heat inactivation of serum on aggregation of immunoglobulins.

Authors:  R D Soltis; D Hasz; M J Morris; I D Wilson
Journal:  Immunology       Date:  1979-01       Impact factor: 7.397

6.  Macrophage function during Trypanosoma musculi infection in mice.

Authors:  P Vincendeau; A Caristan; R Pautrizel
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

7.  Immunological clearance of 75Se-labelled Trypanosoma brucei in mice. II. Mechanisms in immune animals.

Authors:  J A Macaskill; P H Holmes; D D Whitelaw; I McConnell; F W Jennings; G M Urquhart
Journal:  Immunology       Date:  1980-08       Impact factor: 7.397

8.  Trypanosoma musculi: transfer of immunity from mother mice to litter.

Authors:  S Brenière; P Viens
Journal:  Can J Microbiol       Date:  1980-09       Impact factor: 2.419

9.  Differences in resistance to Trypanosoma musculi infection among strains of inbred mice.

Authors:  J W Albright; J F Albright
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

10.  The four subclasses of IgG can be isolated from mouse serum by using Protein A-Sepharose.

Authors:  I Seppälä; H Sarvas; F Péterfy; O Mäkelä
Journal:  Scand J Immunol       Date:  1981-10       Impact factor: 3.487

View more
  12 in total

1.  Cells within the vascular system capable of mediating trypanocidal activity in vitro.

Authors:  K T Shaw; Y Mawji; M M Stevenson; P A Kongshavn
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

2.  Hepatic cells' mitotic and peritoneal macrophage phagocytic activities during Trypanosoma musculi infection in zinc-deficient mice.

Authors:  P A Humphrey; M Ashraf; C M Lee
Journal:  J Natl Med Assoc       Date:  1997-04       Impact factor: 1.798

3.  Cooperative action of complement component C3 and phagocytic effector cells in innate murine resistance to Trypanosoma lewisi.

Authors:  B B Desai; J W Albright; J F Albright
Journal:  Infect Immun       Date:  1987-02       Impact factor: 3.441

4.  Failure to demonstrate a major role for Kupffer cells and radiosensitive leukocytes in immunoglobulin-mediated elimination of Trypanosoma musculi.

Authors:  P A Kongshavn; K Shaw; E Ghadirian; O Ulczak
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

5.  The liver as a major site of immunological elimination of murine trypanosome infection, demonstrated with the liver perfusion model.

Authors:  J W Albright; G W Long; J F Albright
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

6.  Identification of antibody classes and Fc receptors responsible for phagocytosis of Trypanosoma musculi by mouse macrophages.

Authors:  P Vincendeau; M Daëron; S Daulouede
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

7.  In vitro assay for curative activity in blood of mice infected with Trypanosoma musculi.

Authors:  D S Wechsler; P A Kongshavn
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

8.  Further characterization of the curative antibodies in Trypanosoma musculi infection.

Authors:  D S Wechsler; P A Kongshavn
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

9.  Changes in immunoglobulin levels in zinc-deficient mice infected with Trypanosoma musculi.

Authors:  P A Humphrey; C M Lee; M Ashraf
Journal:  J Natl Med Assoc       Date:  1994-08       Impact factor: 1.798

10.  Antimalarial antibodies of the immunoglobulin G2a isotype modulate parasitemias in mice infected with Plasmodium yoelii.

Authors:  W I White; C B Evans; D W Taylor
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.